Patent · US Active

Assessing transplant complication risk with total cell-free DNA

US11773434B2 · kind B2 · utility

0Cited by

13References

9Claims

0Family size

Assignee

The Medical College of Wisconsin, Inc. · US

Inventors

Aoy Tomita Mitchell · Elm Grove, US
Michael Mitchell · Elm Grove, US

Key dates

Filing date	Jun 20, 2018
Grant date	Oct 3, 2023
Priority date	—
Expiry date	Mar 23, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention relates to methods and compositions for assessing an amount of total cell-free DNA, such as from a transplant subject. The methods and composition provided herein can be used to determine risk of complications following transplantation, including infection, cardiac arrest, and death, in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.